{
    "nct_id": "NCT05328167",
    "official_title": "Contrast-Enhanced Ultrasound for Diagnosis and Therapy of Cholangiocarcinoma",
    "inclusion_criteria": "* Be scheduled for sub-lobar radioembolization therapy of a previously untreated intrahepatic cholangiocarcinoma greater than 1 cm but small enough to be fully visualized in the ultrasound three-dimensional (3D) volume (approximately 6 cm maximum diameter, but depth dependent)\n* Be at least 18 years of age\n* Be medically stable\n* If a female of child-bearing age, have a negative pregnancy test prior to each ultrasound exam\n* Have signed Informed Consent to participate in the study\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Females who are pregnant or nursing\n* Patients with recent cerebral hemorrhage\n* Patients with known sensitivities to albumin, blood, or blood products\n* Patients with known hypersensitivity to perflutren\n* Patients with known congenital heart defects\n* Patients with severe emphysema, pulmonary vasculitis, or a history of pulmonary emboli\n* Patients with bilirubin levels > 2 mg/dL",
    "miscellaneous_criteria": ""
}